BIOBusinesSolutions | Elsevier Business Intelligence

Elsevier Business Intelligence
Industry Reports and Databases

Description
BIO has partnered with Elsevier Business Intelligence to provide discounts on Elsevier's suite of publications and databases. This includes Windhover publications IN VIVO, Start-Up, The RPM Report, and MedTech Insight - which provide superior analysis and commentary on health care business strategy, industry dealmaking, and marketplace trends. Windhover's Strategic Transactions database is the most comprehensive deals database in the life science industry.

Elsevier Business Intelligence also offers discounts on FDC Reports publications and the Inteleos drug database. FDC Reports publications such as "The Pink Sheet", "The Gray Sheet", PharmAsia News, and Pharmaceutical Approvals Monthly, among others, provide the latest regulatory, legislative, and business news affecting the U.S. drug, biotechnology, medical device, and nonprescription drug industries. Inteleos is an online business intelligence database, designed to help professionals track drug development activity from late-stage preclinical to launch and post-marketing studies. This comprehensive database, which is updated daily, covers 12,000+ drugs from 3,000+ companies.

Member Benefits**:

	Discounts ranging from 17% to 50% off Windhover's standard published rates on Windhover publications: IN VIVO, Start-Up, The RPM Report, and MedTech Insight (Note: the discount is based on the publication selected)
	Discount of 15% off the standard rate for Windhover's Strategic Transactions database
	Publications discounted further when purchased in conjunction with Windhover's Strategic Transactions database
	Discount of 30% off the standard rate for FDC Reports publications: "The Pink Sheet", "The Pink Sheet" Daily, PharmAsia News, "The Gray Sheet", and Pharmaceutical Approvals Monthly
	Discount of 15% off the standard rate for the Inteleos database
**Discounts are for new subscriptions only.

Eligible Association Members
Many state/regional biotechnology associations have partnered with BIO to offer their members the benefits of the BIO Business Solutionssm program.

More Information
For more information about the BIO-Elsevier program, contact Ida Stepinac of Elsevier Business Intelligence at 203-838-4401, x128, or I.Stepinac@Elsevier.com.

To learn more about Elsevier Business Intelligence, visit www.elsevier.com and FDC Reports, visit www.FDCReports.com.

FreeMind Group: Assists with NIH and DOD funding opportunities. FreeMind specializes in raising funds from government agencies and other non-dilutive sources through grants and contracts.

Nature Publishing Group is offering a Pay-Per-View access option for NPG journals. Member companies can view and download individual articles published in any of the journals on the NPG platform.

Not a BIO member? You still may be eligible. View the list of participating state/regional biotech associations.

"The BIO Business Solutions program is very valuable to a company, especially now. Everybody is looking to save money in any way they can, and some ways are, frankly, quite painful. This one is a method that is not painful at all - in fact, it is easy. We pretty much do what we've always done; we're just paying less money for the same things. It's a win-win." Matt Pfeffer, Corporate Vice President and Chief Financial Officer, MannKind Corporation

Elsevier Business Intelligence

Elsevier Business Intelligence Industry Reports and Databases

Elsevier Business Intelligence
Industry Reports and Databases